ELP1 and Fabry disease: This work demonstrated that, in fact, the metabolome of FD patients differs significantly from their cohabitating healthy (heterozygous for the ELP1 mutation) relatives and provided valuable insights into the link between alterations in central metabolic pathways, progressive neurodegeneration, and clinical phenotypes of FD patients [20,21].